|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-0.77/--
|
Enterprise Value
149.96M
|
Balance Sheet |
Book Value Per Share
0.20
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
324.24M
|
Operating Revenue Per Share
3.88
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2025/01/20 23:02 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. |